Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9106
|
pubmed:dateCreated |
1998-4-10
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0140-6736
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
21
|
pubmed:volume |
351
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
877-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9525367-Craniosynostoses,
pubmed-meshheading:9525367-Deafness,
pubmed-meshheading:9525367-Hearing Loss, Sensorineural,
pubmed-meshheading:9525367-Humans,
pubmed-meshheading:9525367-Pedigree,
pubmed-meshheading:9525367-Point Mutation,
pubmed-meshheading:9525367-Receptors, Fibroblast Growth Factor
|
pubmed:year |
1998
|
pubmed:articleTitle |
Deafness due to Pro250Arg mutation of FGFR3.
|
pubmed:publicationType |
Letter,
Research Support, Non-U.S. Gov't
|